Sanofi plans up to USD 1.6 billion investment in Germany: Handelsblatt Ruchika Sharma2 July 2024 2:50 PM ISTFrankfurt: French pharmaceutical company, Sanofi, is close to deciding on an investment ranging between 1.3 billion euros and 1.5 billion euros...
GoodRx to offer Sanofi insulin injection Lantus for only USD 35 in US Ruchika Sharma24 Oct 2023 10:00 AM ISTUnited States: GoodRx has said it has collaborated with Sanofi to offer the drugmaker's most-prescribed insulin injection Lantus for only $35...
Indian Pharma Market registers 11 percent growth in April: IQVIA Farhat Nasim24 May 2023 11:51 AM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has reported double-digit growth of 11 percent for the month of April 2023, according to IQVIA.On a...
IPM grew 19 percent in March, brands like Calpol, Augmentin observed highest growth: IQVIA Farhat Nasim12 April 2023 6:09 PM ISTNew Delhi: The Indian pharmaceutical market reported double-digit growth of 19 percent in the month of March 2023, according to IQVIA. The...
Sanofi cuts US list price of Lantus, its most-prescribed insulin by 78 percent Ruchika Sharma17 March 2023 12:15 PM ISTParis: Sanofi has announced that it will cut the list price of Lantus (insulin glargine injection) 100 Units/mL, its most widely prescribed insulin in...
Biocon Biologics partner Viatris wins US court decision on 5 Sanofi Lantus SoloSTAR device patents Ruchika Sharma31 Dec 2021 5:12 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that the U.S. Court of Appeals for the Federal Circuit (USCAFC) has ...
Biocon Biologics, Viatris launch interchangeable biosimilars Semglee, Insulin Glargine injections in US Ruchika Sharma17 Nov 2021 11:30 AM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. today announced the U.S. launch of interchangeable biosimilars SEMGLEE...
Biocon, Mylan get USFDA approval for insulin glargine injection Semglee Ruchika Sharma12 Jun 2020 1:17 PM ISTSemglee has an identical amino acid sequence to Sanofi's Lantus® and is approved for the same indications
FDA approves Basaglar, the first follow-on insulin glargine product to treat diabetes savita thakur thakur17 Dec 2015 11:17 AM ISTThe U.S. Food and Drug Administration approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control...
